IMPORTANT SAFETY INFORMATION: The safety of NexHATM has not been evaluated in breeding stallions or in breeding, pregnant, or lactating mares. The following adverse reactions have been reported following intravenous use of NexHA Injectable Solution: occasional depression, lethargy, and fever. NexHA is approved only for intravenous injection. ©2024 Vetoquinol USA, Inc., the Vetoquinol logo is a registered trademark and NEXHA is a trademark of Vetoquinol USA, Inc. Legend is a registered trademark of Boehringer Ingelheim.
1 Gupta, R.C., Lall, R., Srivastava, A. Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Front Vet Sci. 2019 Jun 25:6:192.
2 Goodrich, L.R., and Nixon, A.J., Medical Treatment of Osteoarthritis in the Horse – A Review. The Veterinary Journal. 2006; 51-69.